Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01138735 · ClinicalTrials.gov registry record · Phase 4
Epiduo Pediatric Acne Study
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 285
- Enrollment target
NCT01138735 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 285 participants.
The verdict
NCT01138735, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 285 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% administered once daily for up to 12 weeks in subjects 9 to 11 years of age with acne vulgaris.
Interventions
- DRUG Topical Gel Vehicle
- DRUG adapalene/benzoyl peroxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 285 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01138735
The ClinicalTrials.gov registry entry for NCT01138735 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 285 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Topical Gel Vehicle is the first listed.
NCT01138735 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01138735 about?
NCT01138735 is a clinical study titled "Epiduo Pediatric Acne Study". The purpose of this study is to evaluate the safety and efficacy of Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% administered once daily for up to 12 weeks in subjects 9 to 11 years of age with acne vulgaris.
What is the current status of trial NCT01138735?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 285 participants. The study started on 2010-06. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01138735?
The interventions under investigation include: Topical Gel Vehicle (DRUG), adapalene/benzoyl peroxide (DRUG).
Who is sponsoring clinical trial NCT01138735?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.